Rankings
▼
Calendar
BMRN Q2 2025 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$825M
+15.9% YoY
Gross Profit
$675M
81.8% margin
Operating Income
$277M
33.5% margin
Net Income
$241M
29.1% margin
EPS (Diluted)
$1.23
QoQ Revenue Growth
+10.8%
Cash Flow
Operating Cash Flow
$185M
Free Cash Flow
$168M
Stock-Based Comp.
$48M
Balance Sheet
Total Assets
$7.5B
Total Liabilities
$1.4B
Stockholders' Equity
$6.0B
Cash & Equivalents
$1.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$825M
$712M
+15.9%
Gross Profit
$675M
$582M
+16.1%
Operating Income
$277M
$120M
+129.9%
Net Income
$241M
$107M
+124.4%
Revenue Segments
Product
$813M
98%
Royalty And Other
$12M
2%
← FY 2025
All Quarters
Q3 2025 →